Implications of renal function on adverse clinical events in patients with atrial fibrillation: a comparative analysis of VKA and NOAC therapy - Insights from the GLORIA-AF Registry Phase III
Event:
ESC Congress 2024
Topic:
Oral Anticoagulation
Session:
Management of comorbidities and outcomes in atrial fibrillation (2)